Cargando…
Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17/Treg balance in AMPK-dependent mechanisms
BACKGROUND: Pioglitazone (PIO), a thiazolidinediones drug, is a well-known anti-diabetic medicine, but its anti-atherosclerotic effects remain controversial. Thus it is important to investigate the effects of PIO on atherogenesis and the relevant mechanisms. METHODS: For in vitro studies, primary cu...
Autores principales: | Tian, Yuling, Chen, Tao, Wu, Yan, Yang, Lin, Wang, Lijun, Fan, Xiaojuan, Zhang, Wei, Feng, Jiahao, Yu, Hang, Yang, Yanjie, Zhou, Juan, Yuan, Zuyi, Wu, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663071/ https://www.ncbi.nlm.nih.gov/pubmed/29084546 http://dx.doi.org/10.1186/s12933-017-0623-6 |
Ejemplares similares
-
Th17/Treg balance and indoleamine 2,3 dioxygenase activity in periodontitis-associated atherosclerotic patients
por: Yang, Jie, et al.
Publicado: (2022) -
Analysis of atherosclerotic plaque distribution in the carotid artery
por: Yang, Shin‐Seok, et al.
Publicado: (2022) -
The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases
por: Zhang, Siwen, et al.
Publicado: (2021) -
The Balance of Th17 versus Treg Cells in Autoimmunity
por: Lee, Gap Ryol
Publicado: (2018) -
IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients
por: Shi, Yuling, et al.
Publicado: (2019)